Lenvatinib-Induced Tumor Lysis Syndrome in Advanced Hepatocellular Carcinoma

This case report describes a 48-year-old man with hepatocellular carcinoma who developed tumor lysis syndrome (TLS) after 7 days of starting lenvatinib therapy. The patient was hospitalized and received appropriate interventions, including aggressive hydration, allopurinol, rasburicase, and electrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Manjeet Kumar, Singh, Arshdeep, Kumar Gupta, Yogesh, Kaur Dhaliwal, Kanwarpal, Sood, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479354/
https://www.ncbi.nlm.nih.gov/pubmed/37674881
http://dx.doi.org/10.14309/crj.0000000000001139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479354/
https://www.ncbi.nlm.nih.gov/pubmed/37674881
http://dx.doi.org/10.14309/crj.0000000000001139

Ejemplares similares